The molecular mechanism of HDAC inhibitors in anticancer effects.
about
Evolution of the arginase fold and functional diversityMonitoring the effect of belinostat in solid tumors by H4 acetylationHistones: Controlling Tumor Signaling CircuitrySomatic nucleus reprogramming is significantly improved by m-carboxycinnamic acid bishydroxamide, a histone deacetylase inhibitor.Histone deacetylase inhibitors in Hodgkin lymphoma.Antioxidants impair anti-tumoral effects of Vorinostat, but not anti-neoplastic effects of Vorinostat and caspase-8 downregulationDynamic structure-based pharmacophore model development: a new and effective addition in the histone deacetylase 8 (HDAC8) inhibitor discovery.Targeting Histone Deacetylases in Diseases: Where Are We?The Histone Deacetylase Inhibitor BML-210 Influences Gene and Protein Expression in Human Promyelocytic Leukemia NB4 Cells via Epigenetic Reprogramming.Common gamma chain cytokines in combinatorial immune strategies against cancerVorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition.Histone deacetylase 1 is required for the development of the zebrafish inner ear.The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cellsButyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells.PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells.Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin.Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphomaInhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cells
P2860
Q24642568-0014B39D-5F27-4D82-B698-1B4F03778DD2Q24644030-9B1285F4-1B16-4A0C-A75F-C91C6DF16495Q34109472-63B47F3B-A916-403B-8580-CE5A83EA77DDQ34155461-1896DF7D-22EA-4BEE-B3BB-EAB53052793EQ34414440-E8B4B56D-3CE0-4FD4-9940-F79956606949Q35126359-BF3452F5-9679-4A2F-B8B4-64C17539FA71Q35669576-EA727602-43E5-4773-B36E-0D2F84E5DF61Q35821728-C7DFDE09-9C3D-4D89-93ED-FFB6FB8FE824Q36088554-827DC430-5A3B-4301-BF6B-1CD564A551B9Q36455872-13B50346-4ED3-4648-BBA4-E8996DC65AD7Q36501207-213B1623-663C-43A3-B0B5-83539CA4EA83Q36510301-1CC1CE61-F7A2-41AD-A28B-8FCCE207FF2AQ36527064-23B2A33E-C3D0-4FF1-BCE5-40FBE6EEBA2DQ37197352-D6C78BF9-6AD9-4946-8351-769CEAA1F00CQ37628348-1819AC17-D152-4873-8D89-C36E120D83FEQ39689340-E199D9F5-FB3C-4BE8-AF70-EF8A3AD8DC2FQ39906454-4A4341E6-E0EC-47B5-A808-F3E8492117BFQ39955238-0B3B5748-17AD-4444-A94D-BB2236FAB5F8Q42199704-20F0D54C-91F6-408E-9F5F-986B4829815A
P2860
The molecular mechanism of HDAC inhibitors in anticancer effects.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The molecular mechanism of HDAC inhibitors in anticancer effects.
@ast
The molecular mechanism of HDAC inhibitors in anticancer effects.
@en
type
label
The molecular mechanism of HDAC inhibitors in anticancer effects.
@ast
The molecular mechanism of HDAC inhibitors in anticancer effects.
@en
prefLabel
The molecular mechanism of HDAC inhibitors in anticancer effects.
@ast
The molecular mechanism of HDAC inhibitors in anticancer effects.
@en
P1476
The molecular mechanism of HDAC inhibitors in anticancer effects.
@en
P2093
Gaofeng Bi
Guosheng Jiang
P304
P577
2006-08-01T00:00:00Z